Home » Topics » BioWorld Science

BioWorld Science
RSS

Ascentage Pharma discovers mutant GTPase KRAS inhibitors

Aug. 3, 2021

New CDK and TRK inhibitors identified at Hangzhou Innogate Pharma

Aug. 3, 2021

Bristol Myers Squibb patents CD80/PD-L1 and/or PD-1/PD-L1 interaction inhibitors

Aug. 3, 2021

Hovione Scientia describes ligand drug conjugates including BET inhibitors

Aug. 3, 2021

Vaxart's IND application for S-only oral tablet COVID-19 vaccine cleared in U.S.

Aug. 3, 2021

First patient dosed in phase II study of ZN-c3 in uterine serous carcinoma

Aug. 3, 2021

U.K. MHRA clears initiation of first-in-human study of HMBD-001 in advanced cancers

Aug. 2, 2021

China NMPA accepts IND for phase I study of CAN-103 for Gaucher's disease

Aug. 2, 2021

Lundbeck opens phase I study of Lu-AG-09222 in headache model

Aug. 2, 2021

Lundbeck studies Lu-AG-06466 in phase I for fibromyalgia

Aug. 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...